Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII/CaN signal transduction in diabetic cardiomyopathy.

Saved in:
Bibliographic Details
Title: Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII/CaN signal transduction in diabetic cardiomyopathy.
Authors: Niu QQ; School of Basic Medical Sciences, Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, Xinxiang 453003, China; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang 13200, Malaysia. Electronic address: niuqianqian1995@126.com., Fu ZZ; School of Life and Environmental Sciences, Guilin University of Electronic Technology, Guilin, Guangxi 541004, China., Mao BY; College of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China., Zhang X; College of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China., Wang HD; College of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China., Li P; College of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China., Lin LB; School of Basic Medical Sciences, Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, Xinxiang 453003, China., Xi YT; College of Pharmacy, Xinxiang Medical University, Xinxiang, 453003, China., Yin YL; School of Basic Medical Sciences, Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, Xinxiang 453003, China. Electronic address: yalingyin@xxmu.edu.cn., Kamal NNSNM; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang 13200, Malaysia. Electronic address: niksyazni@usm.my., Lim V; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang 13200, Malaysia. Electronic address: vlim@usm.my.
Source: International immunopharmacology [Int Immunopharmacol] 2025 Mar 26; Vol. 150, pp. 114291. Date of Electronic Publication: 2025 Feb 18.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1705
DOI:10.1016/j.intimp.2025.114291